[go: up one dir, main page]

WO2001012665A3 - Helical cytokine zalpha48 - Google Patents

Helical cytokine zalpha48 Download PDF

Info

Publication number
WO2001012665A3
WO2001012665A3 PCT/US2000/022714 US0022714W WO0112665A3 WO 2001012665 A3 WO2001012665 A3 WO 2001012665A3 US 0022714 W US0022714 W US 0022714W WO 0112665 A3 WO0112665 A3 WO 0112665A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
zalpha48
helical cytokine
cytokine
helical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/022714
Other languages
French (fr)
Other versions
WO2001012665A2 (en
Inventor
Darrell C Conklin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Priority to AU69161/00A priority Critical patent/AU6916100A/en
Priority to EP00957562A priority patent/EP1204681A2/en
Priority to JP2001517563A priority patent/JP2003508032A/en
Priority to CA002381794A priority patent/CA2381794A1/en
Publication of WO2001012665A2 publication Critical patent/WO2001012665A2/en
Publication of WO2001012665A3 publication Critical patent/WO2001012665A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Novel cytokine polypeptides, materials and methods for making them, and method of use are disclosed. The polypeptides comprise at least nine contiguous amino acid residues of SEQ ID NO:2, and may be prepared as polypeptide fusions comprise heterologous sequences, such as affinity tags. The polypeptides and polynucleotides encoding them may be used within a variety of therapeutic, diagnostic, and research applications.
PCT/US2000/022714 1999-08-18 2000-08-18 Helical cytokine zalpha48 Ceased WO2001012665A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU69161/00A AU6916100A (en) 1999-08-18 2000-08-18 Helical cytokine zalpha48
EP00957562A EP1204681A2 (en) 1999-08-18 2000-08-18 Helical cytokine zalpha48
JP2001517563A JP2003508032A (en) 1999-08-18 2000-08-18 Helical cytokine ZALPHA48
CA002381794A CA2381794A1 (en) 1999-08-18 2000-08-18 Helical cytokine zalpha48

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37682699A 1999-08-18 1999-08-18
US09/376,826 1999-08-18

Publications (2)

Publication Number Publication Date
WO2001012665A2 WO2001012665A2 (en) 2001-02-22
WO2001012665A3 true WO2001012665A3 (en) 2001-07-12

Family

ID=23486680

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/022714 Ceased WO2001012665A2 (en) 1999-08-18 2000-08-18 Helical cytokine zalpha48

Country Status (5)

Country Link
EP (1) EP1204681A2 (en)
JP (1) JP2003508032A (en)
AU (1) AU6916100A (en)
CA (1) CA2381794A1 (en)
WO (1) WO2001012665A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020168756A1 (en) 2001-03-23 2002-11-14 Fuji Photo Film Co., Ltd. Particle size variable reactor
US7077982B2 (en) 2001-03-23 2006-07-18 Fuji Photo Film Co., Ltd. Molecular electric wire, molecular electric wire circuit using the same and process for producing the molecular electric wire circuit
JP4294946B2 (en) 2002-12-13 2009-07-15 富士フイルム株式会社 Target detection apparatus, target detection method, and target detection substrate
US7076127B2 (en) 2003-01-14 2006-07-11 Fuji Photo Film Co., Ltd. Optical switch and safety apparatus using the same
WO2005054290A2 (en) * 2003-11-26 2005-06-16 Zymogenetics, Inc. Peptide hormones zalpha48 and zsig97

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999063088A2 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Membrane-bound proteins and nucleic acids encoding the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999063088A2 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Membrane-bound proteins and nucleic acids encoding the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHAIKEN IRWIN M ET AL: "Identifying structure-function relationships in four-helix bundle cytokines: Towards de novo mimetics design.", TRENDS IN BIOTECHNOLOGY, vol. 14, no. 10, 1996, pages 369 - 375, XP004035727, ISSN: 0167-7799 *
DATABASE GENEMBL 30 July 1999 (1999-07-30), STRAUSBERG,R.: "ts84b03.x1 NCI_CGAP_GC6 Homo sapiens cDNA clone IMAGE:2237933 3', mRNA sequence", XP002158512 *

Also Published As

Publication number Publication date
WO2001012665A2 (en) 2001-02-22
CA2381794A1 (en) 2001-02-22
JP2003508032A (en) 2003-03-04
AU6916100A (en) 2001-03-13
EP1204681A2 (en) 2002-05-15

Similar Documents

Publication Publication Date Title
WO2002002626A3 (en) Novel secreted proteins
WO2001029221A3 (en) Proteins and polynucleotides encoding them
EP1092774A3 (en) Borrelia burgdorferi antigen OspA, gene encoding it and uses thereof
CA2263889A1 (en) P-selectin ligand proteins
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
AU7165287A (en) DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
WO2001053312A8 (en) Novel nucleic acids and polypeptides
WO2001053455A3 (en) Novel nucleic acids and polypeptides
NZ505880A (en) IL-18 receptor polypeptides
WO2003060143A3 (en) Efficient protein expression system
EP1688430A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
GR3033328T3 (en) Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis.
EP0907719A4 (en) Human cytokine polypeptide
WO2001012665A3 (en) Helical cytokine zalpha48
WO2001029224A3 (en) Granulocyte peptide homolog zgpa1
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
AU1239997A (en) Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes
WO2001070986A3 (en) Helical protein zalpha51
WO2000058465A3 (en) Flint polypeptide analogs
WO2001066748A3 (en) Full length expressed human polynucleotides and the polypeptides they encode
WO2002059317A3 (en) Cub domain protein zcub3 and materials and methods for making it
WO2001053453A3 (en) Novel bone marrow nucleic acids and polypeptides
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
WO1998025955A3 (en) Cloned glucagon-like peptide-2 receptors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2381794

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000957562

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000957562

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000957562

Country of ref document: EP